Skip to main content

iPSC-Derived Oligodendrocytes

Quick Facts

FeatureInformation
Cell TypeHuman Oligodendrocytes Derived from iPSCs
OriginNeural Progenitor Cell → Oligodendrocyte Lineage
SpeciesHuman
Growth ModeAdherent
ProliferationMinimal (Mature Cells)
Typical Differentiation Time2-5 Months
Biosafety LevelBSL-2

Overview

iPSC-derived oligodendrocytes are human myelinating glial cells generated through directed differentiation of induced pluripotent stem cells (iPSCs). These cells closely model human oligodendrocyte development and provide a physiologically relevant platform for studying myelination, white matter biology, axon-glia interactions, and demyelinating diseases.

Because myelin dysfunction contributes to numerous neurological disorders, iPSC-derived oligodendrocytes have become an essential model for investigating multiple sclerosis, leukodystrophies, ALS, Alzheimer's disease, schizophrenia, and other white matter disorders.


Biological Significance

Oligodendrocytes are the myelinating cells of the central nervous system.

Major functions include:

  • Formation of myelin sheaths
  • Saltatory conduction of action potentials
  • Metabolic support of axons
  • Maintenance of long-term neuronal integrity
  • White matter development
  • Neural circuit maturation
  • Remyelination following injury
  • Axon-glia communication

A single mature oligodendrocyte can myelinate multiple axons simultaneously, making these cells essential for efficient CNS function.


Developmental Origin

Somatic Cell

Cellular Reprogramming

Induced Pluripotent Stem Cell

Neural Progenitor Cell

Oligodendrocyte Progenitor Cell (OPC)

Pre-Myelinating Oligodendrocyte

Mature Oligodendrocyte

Unique Features

Compared with immortalized oligodendrocyte cell lines and primary rodent oligodendrocytes, iPSC-derived oligodendrocytes provide:

  • Human-specific myelin biology
  • Patient-specific genetics
  • Unlimited renewable cell source
  • Native developmental progression through the OPC stage
  • Compatibility with neuron co-culture systems
  • Integration into brain organoids
  • High translational relevance for remyelination therapies

Morphology

Oligodendrocyte Progenitor Cells (OPCs)

  • Small bipolar cells
  • Migratory appearance
  • Simple cellular processes

Immature Oligodendrocytes

  • Increased branching
  • Multiple fine cellular processes

Mature Oligodendrocytes

  • Highly branched morphology
  • Membrane sheet formation
  • Myelin-like membrane extensions

Cell Markers

OPC Markers

MarkerFunction
NG2 (CSPG4)OPC marker
PDGFRαOPC receptor
Olig2Oligodendrocyte lineage
NKX2.2Oligodendrocyte specification

Mature Oligodendrocyte Markers

MarkerFunction
MBPMyelin Basic Protein
PLP1Proteolipid Protein
MOGMyelin Oligodendrocyte Glycoprotein
MAGMyelin-Associated Glycoprotein

Common Validation Panel

OPCs

PDGFRα

NG2

Olig2

Mature Oligodendrocytes

MBP

PLP1

MOG


Functional Characterization

Common functional assays include:

  • Myelination assays
  • Neuron-oligodendrocyte co-culture
  • Axonal wrapping analysis
  • Internode formation
  • Electrophysiological studies
  • Myelin protein expression
  • White matter development studies

Disease Modeling Applications

iPSC-derived oligodendrocytes are widely used for studying disorders involving myelin dysfunction.

Demyelinating Disorders

Examples include:

  • Multiple sclerosis (MS)
  • Pelizaeus-Merzbacher disease
  • Krabbe disease
  • Metachromatic leukodystrophy

Common readouts include:

  • OPC differentiation
  • Remyelination
  • MBP expression
  • Myelin sheath formation
  • Cell survival

Neurodegenerative Disorders

Examples include:

  • Amyotrophic lateral sclerosis (ALS)
  • Alzheimer's disease
  • Parkinson's disease

Applications include:

  • White matter pathology
  • Axonal support
  • Oligodendrocyte dysfunction
  • Neurodegeneration studies

Neuropsychiatric Disorders

Examples include:

  • Schizophrenia
  • Autism spectrum disorders

Applications include:

  • Myelin-associated gene expression
  • Oligodendrocyte maturation
  • Neural connectivity studies

Brain Organoid Applications

iPSC-derived oligodendrocytes are increasingly incorporated into:

  • Cortical organoids
  • Brain organoids
  • Myelinating organoid systems

Applications include:

  • Human myelination
  • White matter development
  • Axon-glia interactions
  • Disease modeling

Drug Discovery Applications

Widely used for:

  • Remyelination screening
  • OPC differentiation studies
  • Myelin repair therapies
  • Neuroprotective drug discovery
  • White matter therapeutics

Gene Editing Applications

Frequently combined with:

  • CRISPR-Cas9
  • Base editing
  • Prime editing

Applications include:

  • Myelin gene studies
  • Mutation correction
  • Functional genomics
  • Isogenic controls

Advantages

  • Human-derived cells
  • Patient-specific genetics
  • Human myelin biology
  • Native OPC developmental stage
  • Suitable for myelination assays
  • Compatible with neuron co-cultures
  • Strong translational relevance

Limitations

  • Long differentiation timelines
  • Complex differentiation protocols
  • Batch variability
  • Incomplete maturation possible
  • Expensive culture systems
  • Functional myelination often requires neuronal co-culture

Comparison with Primary Oligodendrocytes

FeatureiPSC-Derived OligodendrocytesPrimary Oligodendrocytes
SpeciesHumanUsually Rodent
Patient-SpecificYesNo
AvailabilityUnlimitedLimited
Disease ModelingExcellentModerate
Physiological RelevanceHighHigh
Translational RelevanceExcellentModerate

Comparison with MO3.13 Cells

FeatureiPSC-Derived OligodendrocytesMO3.13 Cells
Human Primary-Like BiologyHighModerate
Myelination CapacityHighLimited
Patient-SpecificYesNo
Disease ModelingExcellentModerate
Ease of CultureModerateEasy

Key Takeaways

  • iPSC-derived oligodendrocytes closely model human oligodendrocyte development through the OPC stage.
  • They are the preferred human model for studying myelination, remyelination, and white matter biology.
  • Their ability to form myelin around neurons makes them essential for investigating demyelinating diseases.
  • They integrate effectively into neuron co-cultures and brain organoids, enabling advanced CNS disease models.
  • Their patient-specific genetics make them highly valuable for precision medicine and regenerative neuroscience.

References

  • Douvaras P, Fossati V. Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nature Protocols (2015).
  • Ehrlich M et al. Rapid and efficient generation of oligodendrocytes from human iPSCs. Stem Cell Reports (2017).
  • Goldman SA, Kuypers NJ. How to make an oligodendrocyte. Development (2015).
  • Sim FJ et al. Human iPSC-derived oligodendrocytes and myelination studies. Glia (2011).